美股市場個股詳情
DNLI Denali Therapeutics
- 19.750
- +0.450+2.33%
收盤價 05/14 16:00 (美東)
- 19.360
- -0.390-1.97%
盤後 16:10 (美東)
28.17億總市值-21010市盈率TTM
20.280最高價19.470最低價92.07萬股成交量19.880今開19.300昨收1814.97萬成交額0.75%換手率虧損市盈率(靜)1.43億總股本33.31052周最高1.94市淨率24.32億流通值14.56052周最低--股息TTM1.23億流通股93.940歷史最高--股息率TTM4.20%振幅12.320歷史最低19.713平均價1股每手
分析
目標價預測
暫無數據
熱議
美股
綜合熱度
股票代碼
最新價
漲跌幅
Denali Therapeutics股票討論區
Here are some top stocks in the sector climbing on drug trial and earnings news:
$Janux Therapeutics (JANX.US)$shares shot up 205% to $36.00 after the company announced updated clinical data for both of its clinical programs, reaching over $1.50B in market cap.
$Ligand Pharmaceuticals (LGND.US)$gained 23%...
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$阿里拉姆制藥(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
$Regenxbio(RGNX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$EyePoint Pharmaceuticals(EYPT.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$阿里拉姆制藥(ALNY.US)$ Phase 2
$Disc Medicine(IRON.US)$ Phase 2
$Atea Pharmaceuticals(AVIR.US)$ Phase 2
$Allakos(ALLK.US)$ Phase 2...
ON THE WATCH: $33.07
FIRST SIGNED OF MORE UPTREND: $33.14
NEED IT TO BREAK OVER: $33.25
key indicator for MORE uptrend $33.50
confirmation uptrend - $33.68
mini breakout - $33.83. $Denali Therapeutics(DNLI.US)$
暫無評論